SynthesisFrontiers in immunology2025

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Yongfa Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.